Targeting ALK in patients with advanced Non Small Cell Lung Cancer: Biology, diagnostic and therapeutic options-Reference-Cited by-同舟云学术

Targeting ALK in patients with advanced Non Small Cell Lung Cancer: Biology, diagnostic and therapeutic options

Published:2014-03 Issue:3 Volume:89 Page:358-365
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Lazzari Chiara,Spitaleri Gianluca,Catania Chiara,Barberis Massimo,Noberasco Cristina,Santarpia Mariacarmela,Delmonte Angelo,Toffalorio Francesca,Conforti Fabio,De Pas Tommaso Martino

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference53 articles.

1. Identification of the transforming EML4-ALK fusion gene in non small cell lung cancer;Soda;Nature,2007

2. Anaplastic lymphoma kinase inhibition in non small cell lung cancer;Kwak;N Engl J Med,2010

3. Activity and safety of crizotinib in patients with ALK positive non small cell lung cancer: updated results from a phase 1 study;Camidge;Lancet Oncol,2012

4. Crizotinib versus chemotherapy in advanced ALK positive lung cancer;Shaw;N Engl J Med,2013

5. The anaplastic lymphoma kinase in the pathogenesis of cancer;Chiarle;Nat Rev Cancer,2008

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding the feasibility of chemotherapeutic and immunotherapeutic targets against non-small cell lung cancers: an update of resistant responses and recent combinatorial therapies;Exploration of Targeted Anti-tumor Therapy;2023-10-10

2. Therapeutic Advances of Rare ALK Fusions in Non-Small Cell Lung Cancer;Current Oncology;2022-10-16

3. Non-small-cell lung cancer: how to manage ALK-, ROS1- and NTRK-rearranged disease;Drugs in Context;2022-10-12

4. Gewebebasierte Diagnostik des Lungenkarzinoms – Morphologie und molekulare Diagnostik;Onkologische Welt;2021-06

5. Gewebebasierte Diagnostik des Lungenkarzinoms – Morphologie und molekulare Diagnostik;Der Nuklearmediziner;2021-03